查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1706961

2025年全球检体可用性测试市场报告

Specimen Validity Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年检体有效性测试的市场规模将强劲成长。到 2029 年，这一数字将成长至 57.6 亿美元，年复合成长率（CAGR）为 9.3%。预测期内的增长归因于职场药物测试的需求不断增长、口腔液体测试的采用日益增多、研发业务的增加、SVT 的使用不断增加以及疼痛管理应用的不断扩大。预测期内的关键趋势包括技术进步、人工智慧整合用于结果解释、产品创新、增加伙伴关係以及开发用于随时随地监控的携带式测试设备。

预计药物滥用的增加将推动检体有效性测试 (SVT) 市场的扩张。药物滥用是指频繁、过度或不适当地非医疗使用合法或非法药物。药物滥用的增加是由几个相互关联的因素造成的，包括阿片类药物氾滥、精神健康问题日益严重、获得治疗和支持资源的机会有限，以及流行文化中对吸毒的描述。 SVT 方法旨在透过分析 pH 值、比重、肌酸酐水平和温度等各种参数来检测杂质或物质的存在。例如，2023年10月，英国政府机构健康改善与差异办公室报告称，2021年4月至2022年3月期间，参与药物和酒精计画的成年人数量从上一年的28万人增加到29万人。此外，英国政府机构国家统计局于2024年10月透露，预计2023年英格兰和威尔斯因药物中毒死亡的人数将达到5,448人，比2022年记录的4,907人增加11.0%。因此，药物滥用发生率的上升预计将促进检体有效性测试市场的成长。

为了维持市场地位，检体有效性测试市场的主要企业正专注于开发创新产品，例如高解析度尿液药物测试概况。高解析度尿液药物测试概况采用先进的分析技术进行复杂的测试。例如，2022 年 7 月，梅奥诊所实验室推出了数据驱动的尿液药物检测 (UDT) 檔案，旨在为医生提供全面的信息，以管理对处方阿片类药物、酒精、大麻和尼古丁等常见物质上瘾的患者。成瘾药物监测概况 (Mayo ID ADMPU) 与美国成瘾医学协会指南相一致，可为检​​测一系列药物类别（包括阿片类药物、苯二氮平类药物、兴奋剂和 PCP）的母体药物和代谢物提供更高的灵敏度和特异性。该概况利用高解析度、高精度质谱和标靶免疫检测测定技术，为医疗保健专业人员提供临床相关资讯。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球检体效度测试市场的 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球检体有效性测试市场：成长率分析
  • 全球检体可用性测试市场表现：规模与成长，2019-2024 年
  • 全球检体可用性测试市场预测：规模与成长，2024-2029 年，2034 年
  • 全球检体验证测试总目标市场（TAM）

第六章市场区隔

  • 全球检体可用性测试市场（依产品及服务、绩效及预测）2019-2024 年、2024-2029 年、2034 年
  • 产品
  • 服务
  • 全球检体可用性测试市场（按测试类型、效能和预测）2019-2024 年、2024-2029 年、2034 年
  • 实验室测试
  • 快速或就地检验
  • 全球检体可用性测试市场（依最终使用者、绩效及预测）2019-2024、2024-2029、2034
  • 戒毒中心
  • 药物筛检实验室
  • 疼痛管理中心
  • 刑事司法和执法
  • 其他的
  • 全球检体功效测试市场：按类型、性能和预测进行的产品细分，2019-2024 年、2024-2029 年、2034 年
  • 试剂和检测试剂套件
  • 控制设备和校准器
  • 检体装置
  • 分析仪/设备
  • 全球检体可用性测试市场：按类型、效能和预测的服务细分，2019-2024 年、2024-2029 年、2034 年
  • 实验室测试服务
  • 就地检验服务

第七章 区域和国家分析

  • 全球检体可用性测试市场（按地区、绩效及预测）2019-2024 年、2024-2029 年、2034 年
  • 全球检体可用性测试市场（依国家/地区、绩效及预测）2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 检体可用性测试市场：竞争格局
  • 检体有效性测试市场：公司简介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Becton, Dickinson and Company
  • Laboratory Corporation
  • Quest Diagnostics Incorporated
  • Alere Inc.
  • Clinical Reference Laboratory Inc.
  • Precision Diagnostics
  • ACM Global Laboratories
  • Millennium Health
  • Omega Laboratories Inc.
  • Dominion Diagnostics
  • CannAmm
  • Sciteck Inc.
  • Starplex Scientific Inc.
  • Vision Diagnostics Inc.
  • Premier Biotech Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年检体有效性测试市场：提供新机会的国家
  • 2029年检体有效性测试市场：细分市场带来新机会
  • 2029年检体功效测试市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r31284

Specimen Validity Testing (SVT) is a crucial process utilized to evaluate the integrity and authenticity of biological specimens, including urine, blood, saliva, or hair samples, collected for drug testing or clinical analysis. SVT scrutinizes diverse parameters such as pH, creatinine levels, specific gravity, and the presence of common masking agents such as oxidizing adulterants, nitrites, glutaraldehyde, and pyridinium chlorochromate.

Within the specimen validity testing market, products and services are the main offerings. Products encompass assay kits, reagents, calibrators, and disposables employed in the testing procedure to identify any adulteration, dilution, or substitution in urine samples. Various testing types include laboratory testing and rapid or point-of-care testing, catering to a range of end-users such as drug rehabilitation centers, drug screening laboratories, pain management centers, criminal justice and law enforcement agencies, among others.

The specimen validity testing market research report is one of a series of new reports from The Business Research Company that provides specimen validity testing market statistics, including the specimen validity testing industry global market size, regional shares, competitors with a specimen validity testing market share, detailed specimen validity testing market segments, market trends, and opportunities, and any further data you may need to thrive in the specimen validity testing industry. This specimen validity testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The specimen validity testing market size has grown strongly in recent years. It will grow from $3.68 billion in 2024 to $4.03 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing drug adoption, increased drug screening, stringent regulations, increased alcohol use, and integration of point-of-care testing.

The specimen validity testing market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rising demand for workplace drug testing, growing adoption of oral fluid testing, rise in research and development operations, rising usage of SVTand expanding applications in pain management. Major trends in the forecast period include technological advancements, integration of artificial intelligence for result interpretation, product innovations, increasing partnerships, and the development of portable testing devices for on-the-go monitoring.

The growing issue of drug abuse is anticipated to drive the expansion of the specimen validity testing (SVT) market. Drug abuse refers to the frequent, excessive, or inappropriate use of legal or illegal substances for non-medical purposes. The rise in drug abuse can be attributed to multiple interrelated factors, including the opioid epidemic, increasing mental health challenges, limited access to treatment and support resources, and portrayals of drug use in popular culture. SVT methods are designed to detect the presence of impurities and substances by analyzing various parameters such as pH, specific gravity, creatinine levels, and temperature. For example, in October 2023, the Office for Health Improvement and Disparities, a UK government agency, reported an increase in adult interactions with drug and alcohol programs, from 0.28 million in the previous year to 0.29 million between April 2021 and March 2022. Furthermore, in October 2024, the Office for National Statistics, a UK government body, revealed that drug poisoning-related deaths in England and Wales reached 5,448 in 2023, marking an 11.0% increase from the 4,907 deaths recorded in 2022. As a result, the rising incidence of drug abuse is expected to contribute to the growth of the specimen validity testing market.

Key players in the specimen validity testing market are focused on developing innovative products such as high-resolution urine drug testing profiles to maintain their market position. A high-resolution urine drug testing profile employs advanced analytical techniques for sophisticated testing. For instance, in July 2022, Mayo Clinic Laboratories introduced a data-driven urine drug testing (UDT) profile aimed at providing physicians with comprehensive information to manage patients addicted to common substances such as prescription opioids, alcohol, marijuana, and nicotine. This addiction medicine monitoring profile (Mayo ID ADMPU) complies with the American Society of Addiction Medicine's guidelines and offers enhanced sensitivity and specificity to detect parent drugs and metabolites from various drug classes, including opioids, benzodiazepines, stimulants, and PCP. Utilizing high-resolution, accurate mass spectrometry and targeted immunoassay testing, the profile delivers clinically relevant information for healthcare providers.

In November 2024, SPT Labtech, a UK-based company specializing in the design and manufacturing of automated laboratory instruments, formed a partnership with ICE Bioscience. This collaboration aims to advance drug discovery by leveraging state-of-the-art drug screening and automation technologies. By improving assay development and expanding research capabilities, the partnership seeks to drive innovation in the pharmaceutical industry. ICE Bioscience, based in China, is a provider of drug screening platforms.

Major companies operating in the specimen validity testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Medline Industries Inc., Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Alere Inc., Clinical Reference Laboratory Inc., Precision Diagnostics, ACM Global Laboratories, Millennium Health, Omega Laboratories Inc., Dominion Diagnostics, CannAmm, Sciteck Inc., Starplex Scientific Inc., Vision Diagnostics Inc., Premier Biotech Inc., Alfa Scientific Designs, Express Diagnostics, American Bio Medica Corporation, Titan Biotech Ltd., SureHire, Miraclean Technology Co. Ltd.

North America was the largest region in the specimen validity testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specimen validity testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the specimen validity testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The specimen validity testing market includes revenues earned by entities by creatinine testing, pH testing, adulterant testing, and specific gravity measurement and related specimen collection containers, urine test strips, adulterant detection kits, and temperature strips. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Specimen Validity Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on specimen validity testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for specimen validity testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The specimen validity testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Service: Products; Service
  • 2) By Testing Type: Laboratory Testing; Rapid Or Point-Of-Care Testing
  • 3) By End-User: Drug Rehabilitation Centers; Drug Screening Laboratories; Pain Management Centers; Criminal Justice And Law Enforcement Agencies; Other End-Users
  • Subsegments:
  • 1) By Products: Reagents And Assay Kits; Controls And Calibrators; Specimen Collection Devices; Analyzers And Instruments
  • 2) By Service: Laboratory Testing Services; Point-Of-Care Testing Services
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers ; Medline Industries Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Specimen Validity Testing Market Characteristics

3. Specimen Validity Testing Market Trends And Strategies

4. Specimen Validity Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Specimen Validity Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Specimen Validity Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Specimen Validity Testing Market Growth Rate Analysis
  • 5.4. Global Specimen Validity Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Specimen Validity Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Specimen Validity Testing Total Addressable Market (TAM)

6. Specimen Validity Testing Market Segmentation

  • 6.1. Global Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Products
  • Service
  • 6.2. Global Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Testing
  • Rapid Or Point-Of-Care Testing
  • 6.3. Global Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Rehabilitation Centers
  • Drug Screening Laboratories
  • Pain Management Centers
  • Criminal Justice And Law Enforcement Agencies
  • Other End-Users
  • 6.4. Global Specimen Validity Testing Market, Sub-Segmentation Of Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents And Assay Kits
  • Controls And Calibrators
  • Specimen Collection Devices
  • Analyzers And Instruments
  • 6.5. Global Specimen Validity Testing Market, Sub-Segmentation Of Service, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Testing Services
  • Point-Of-Care Testing Services

7. Specimen Validity Testing Market Regional And Country Analysis

  • 7.1. Global Specimen Validity Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Specimen Validity Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Specimen Validity Testing Market

  • 8.1. Asia-Pacific Specimen Validity Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Specimen Validity Testing Market

  • 9.1. China Specimen Validity Testing Market Overview
  • 9.2. China Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Specimen Validity Testing Market

  • 10.1. India Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Specimen Validity Testing Market

  • 11.1. Japan Specimen Validity Testing Market Overview
  • 11.2. Japan Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Specimen Validity Testing Market

  • 12.1. Australia Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Specimen Validity Testing Market

  • 13.1. Indonesia Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Specimen Validity Testing Market

  • 14.1. South Korea Specimen Validity Testing Market Overview
  • 14.2. South Korea Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Specimen Validity Testing Market

  • 15.1. Western Europe Specimen Validity Testing Market Overview
  • 15.2. Western Europe Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Specimen Validity Testing Market

  • 16.1. UK Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Specimen Validity Testing Market

  • 17.1. Germany Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Specimen Validity Testing Market

  • 18.1. France Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Specimen Validity Testing Market

  • 19.1. Italy Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Specimen Validity Testing Market

  • 20.1. Spain Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Specimen Validity Testing Market

  • 21.1. Eastern Europe Specimen Validity Testing Market Overview
  • 21.2. Eastern Europe Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Specimen Validity Testing Market

  • 22.1. Russia Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Specimen Validity Testing Market

  • 23.1. North America Specimen Validity Testing Market Overview
  • 23.2. North America Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Specimen Validity Testing Market

  • 24.1. USA Specimen Validity Testing Market Overview
  • 24.2. USA Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Specimen Validity Testing Market

  • 25.1. Canada Specimen Validity Testing Market Overview
  • 25.2. Canada Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Specimen Validity Testing Market

  • 26.1. South America Specimen Validity Testing Market Overview
  • 26.2. South America Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Specimen Validity Testing Market

  • 27.1. Brazil Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Specimen Validity Testing Market

  • 28.1. Middle East Specimen Validity Testing Market Overview
  • 28.2. Middle East Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Specimen Validity Testing Market

  • 29.1. Africa Specimen Validity Testing Market Overview
  • 29.2. Africa Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Specimen Validity Testing Market Competitive Landscape And Company Profiles

  • 30.1. Specimen Validity Testing Market Competitive Landscape
  • 30.2. Specimen Validity Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Specimen Validity Testing Market Other Major And Innovative Companies

  • 31.1. Becton, Dickinson and Company
  • 31.2. Laboratory Corporation
  • 31.3. Quest Diagnostics Incorporated
  • 31.4. Alere Inc.
  • 31.5. Clinical Reference Laboratory Inc.
  • 31.6. Precision Diagnostics
  • 31.7. ACM Global Laboratories
  • 31.8. Millennium Health
  • 31.9. Omega Laboratories Inc.
  • 31.10. Dominion Diagnostics
  • 31.11. CannAmm
  • 31.12. Sciteck Inc.
  • 31.13. Starplex Scientific Inc.
  • 31.14. Vision Diagnostics Inc.
  • 31.15. Premier Biotech Inc.

32. Global Specimen Validity Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Specimen Validity Testing Market

34. Recent Developments In The Specimen Validity Testing Market

35. Specimen Validity Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Specimen Validity Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Specimen Validity Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Specimen Validity Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer